Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamidronate in Breast Cancer Patients With Bone Metastases
NCT00128297Phase 4Completed
- Sponsor
- GEICAM
- Start
- Oct 2000
- Primary completion
- Jun 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pamidronate in bone metastasis (2 arms), sponsored by GEICAM. Primary endpoint: Time until the appearance of the first skeletal event at 18 months. Started Oct 2000; status: completed.
02
Drugs
pamidronate
03
Conditions
bone metastasis
Beyond the preview
Go deeper on NCT00128297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128297.